SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Eddy Jodi Euerle

(Last)

(First)

(Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH

01752-1234

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2018

3. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP and CIO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	14,203⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Deferred Stock Units	⁽²⁾	01/02/2019⁽²⁾	Common Stock	2,099⁽³⁾	⁽⁴⁾	D
Deferred Stock Units	⁽⁵⁾	02/22/2021⁽⁵⁾	Common Stock	5,214⁽⁶⁾	⁽⁴⁾	D
Deferred Stock Units	⁽⁷⁾	02/23/2020⁽⁷⁾	Common Stock	2,208⁽⁸⁾	⁽⁴⁾	D
Deferred Stock Units	⁽⁹⁾	02/24/2019⁽⁹⁾	Common Stock	230⁽¹⁰⁾	⁽⁴⁾	D
Deferred Stock Units	⁽¹¹⁾	02/28/2022⁽¹¹⁾	Common Stock	5,703⁽¹²⁾	⁽⁴⁾	D
Stock Option (Right to Buy)	⁽¹³⁾	02/24/2024	Common Stock	3,000	$13.08	D
Stock Option (Right to Buy)	⁽¹⁴⁾	02/23/2025	Common Stock	16,697	$16.31	D
Stock Option (Right to Buy)	⁽¹⁵⁾	02/22/2026	Common Stock	27,675	$17.26	D
Stock Option (Right to Buy)	⁽¹⁶⁾	02/28/2027	Common Stock	25,252	$24.55	D

Explanation of Responses:

1. Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

2. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on January 2, 2015, the first anniversary of the date of grant.

3. This amount represents the unvested portion of DSUs awarded on January 2, 2014, which will continue to vest in one remaining installment on the anniversary of the date of grant.

4. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

5. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

6. This amount represents the unvested portion of DSUs awarded on February 22, 2016, which will continue to vest in three remaining installments on the anniversary of the date of grant.

7. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.

8. This amount represents the unvested portion of DSUs awarded on February 23, 2015, which will continue to vest in two remaining installments on the anniversary of the date of grant.

9. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.

10. This amount represents the unvested portion of DSUs awarded on February 24, 2014, which will continue to vest in one remaining installment on the anniversary of the date of grant.

11. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

12. This amount represents the unvested portion of DSUs awarded on February 28, 2017, which will continue to vest in four remaining installments on the anniversary of the date of grant.

13. Grant to the reporting person of an option to purchase a 3,000 shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.

14. Grant to the reporting person of an option to purchase a 16,697 shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.

15. Grant to the reporting person of an option to purchase a 27,675 shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

16. Grant to the reporting person of an option to purchase a 25,252 shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Remarks:

eddypoa.txt

	/s/ Vance R. Brown, Attorney-in-fact	04/03/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.